Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Leases (2019 - 2025)

Historic Leases for Harvard Bioscience (HBIO) over the last 7 years, with Q3 2025 value amounting to $7.5 million.

  • Harvard Bioscience's Leases rose 1497.78% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 1497.78%. This contributed to the annual value of $6.1 million for FY2024, which is 2847.27% up from last year.
  • Harvard Bioscience's Leases amounted to $7.5 million in Q3 2025, which was up 1497.78% from $7.1 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Leases ranged from a high of $7.5 million in Q3 2025 and a low of $4.4 million during Q1 2024
  • Moreover, its 5-year median value for Leases was $6.2 million (2022), whereas its average is $6.2 million.
  • Its Leases has fluctuated over the past 5 years, first crashed by 2081.74% in 2024, then skyrocketed by 6707.96% in 2025.
  • Quarter analysis of 5 years shows Harvard Bioscience's Leases stood at $6.9 million in 2021, then dropped by 15.67% to $5.8 million in 2022, then fell by 17.93% to $4.8 million in 2023, then rose by 28.47% to $6.1 million in 2024, then rose by 22.31% to $7.5 million in 2025.
  • Its Leases stands at $7.5 million for Q3 2025, versus $7.1 million for Q2 2025 and $7.3 million for Q1 2025.